Suppr超能文献

β-内酰胺抗生素抑制后,经乙醚通透处理的大肠杆菌中肽聚糖合成的重新激活。

Reactivation of peptidoglycan synthesis in ether-permeabilized Escherichia coli after inhibition by beta-lactam antibiotics.

作者信息

Talbot M K, Schaefer F, Brocks V, Christenson J G

机构信息

Roche Research Center, Nutley, New Jersey 07110.

出版信息

Antimicrob Agents Chemother. 1989 Dec;33(12):2101-8. doi: 10.1128/AAC.33.12.2101.

Abstract

The recovery of peptidoglycan-synthesizing activity after inhibition by beta-lactam antibiotics was investigated in ether-permeabilized cells of Escherichia coli B. Such cells synthesize sodium dodecyl sulfate-insoluble peptidoglycan when provided with UDP-linked precursors and Mg2+. The ability of beta-lactam antibiotics to inhibit the synthesis of peptidoglycan was correlated with their affinity for penicillin-binding proteins 1A and 1Bs. Penicillin-binding protein 1Bs is thought to be the major peptidoglycan synthetase in E. coli and is a major lethal target for beta-lactam antibiotics. Ether-treated bacteria were preincubated with concentrations of beta-lactams sufficient to completely inhibit peptidoglycan synthesis and then treated with beta-lactamases to inactivate free antibiotic prior to measurement of peptidoglycan synthesis. At 40 min after beta-lactamase treatment, the rate of peptidoglycan synthesis was about 74% of the control rate in cells pretreated with ampicillin, but only 15% of the control in cells pretreated with penicillin G or azlocillin. Reversal of inhibition by several other antibiotics fell between these extremes. When cross-linking of peptidoglycan was measured specifically, reversal of inhibition by ampicillin also occurred more readily than that by penicillin G. Reactivation of peptidoglycan synthesis was not due to de novo synthesis of penicillin-binding proteins since it occurred under conditions that did not allow incorporation of [14C]leucine. We conclude that there is considerable variation in the stability of the inactive acyl enzymes formed between various beta-lactams and penicillin-binding protein 1Bs, with those formed by penicillin G being relatively long-lived.

摘要

在大肠杆菌B的经乙醚通透处理的细胞中,研究了β-内酰胺类抗生素抑制后肽聚糖合成活性的恢复情况。当提供UDP连接的前体和Mg2+时,此类细胞可合成十二烷基硫酸钠不溶性肽聚糖。β-内酰胺类抗生素抑制肽聚糖合成的能力与其对青霉素结合蛋白1A和1B的亲和力相关。青霉素结合蛋白1B被认为是大肠杆菌中的主要肽聚糖合成酶,是β-内酰胺类抗生素的主要致死靶点。经乙醚处理的细菌先用足以完全抑制肽聚糖合成的β-内酰胺类药物浓度进行预孵育,然后在用β-内酰胺酶处理以灭活游离抗生素后再测量肽聚糖合成。在β-内酰胺酶处理后40分钟,肽聚糖合成速率在氨苄青霉素预处理的细胞中约为对照速率的74%,但在青霉素G或阿洛西林预处理的细胞中仅为对照的15%。其他几种抗生素抑制作用的逆转情况介于这两个极端之间。当特异性测量肽聚糖的交联时,氨苄青霉素抑制作用的逆转也比青霉素G更容易发生。肽聚糖合成的重新激活并非由于青霉素结合蛋白的从头合成,因为它是在不允许掺入[14C]亮氨酸的条件下发生的。我们得出结论,各种β-内酰胺类药物与青霉素结合蛋白1B形成的无活性酰基酶的稳定性存在很大差异,其中由青霉素G形成的酰基酶相对寿命较长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71bd/172829/9c7a4f23e114/aac00079-0096-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验